Kidney International Reports

Papers
(The H4-Index of Kidney International Reports is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Collapsing Glomerulopathy in a Patient With COVID-19225
Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy171
Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection169
Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis162
COVID-19 Vaccination and Glomerulonephritis124
De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19104
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf299
Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD91
COVID-19–Associated Collapsing Glomerulopathy: An Emerging Entity90
A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease83
Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy81
Randomized Clinical Trial on the Effect of Bardoxolone Methyl on GFR in Diabetic Kidney Disease Patients (TSUBAKI Study)80
Safety of Remdesivir in Patients With Acute Kidney Injury or CKD72
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy69
Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events68
Preventing CKD in Developed Countries68
CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management64
A Systematic Review of COVID-19 and Kidney Transplantation62
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale62
Roxadustat for CKD-related Anemia in Non-dialysis Patients62
IgA Vasculitis With Nephritis (Henoch−Schönlein Purpura) in a COVID-19 Patient59
Current and Investigational Therapeutics for Fabry Disease58
Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance58
Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney Disease57
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations55
Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events54
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy”54
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study53
Complement in Secondary Thrombotic Microangiopathy52
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients52
Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era51
SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease51
Proteomic Analysis of Complement Proteins in Membranous Nephropathy50
COVID-19 in Patients on Maintenance Dialysis in the Paris Region44
Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine44
Decreasing Incidence of Acute Kidney Injury in Patients with COVID-19 Critical Illness in New York City44
The Adverse Effect of COVID Pandemic on the Care of Patients With Kidney Diseases in India43
Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors43
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-1942
Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis42
Dialysis-Induced Cardiovascular and Multiorgan Morbidity40
Epidemiological, Clinical, and Immunological Features of a Cluster of COVID-19–Contracted Hemodialysis Patients40
0.037220001220703